{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:45Z","timestamp":1792794705145,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Hope Pharmaceuticals","id":[{"id":"https:\/\/ror.org\/04ea9we05","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Epizon"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/qjmed\/hcy234","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T07:34:31Z","timestamp":1539070471000},"page":"29-34","source":"Crossref","is-referenced-by-count":29,"title":["Review: update on the management of calciphylaxis"],"prefix":"10.1093","volume":"112","author":[{"given":"H","family":"Seethapathy","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V M","family":"Brandenburg","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Rhein-Maas Klinikum, W\u00fcrselen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Salford Royal NHS Foundation Trust, Manchester Academic Health Sciences Centre, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"El-Azhary","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S U","family":"Nigwekar","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B1","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.mayocp.2016.06.025","article-title":"Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis","volume":"91","author":"McCarthy","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ndt\/gfv438","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): Data from a large nationwide registry","volume":"32","author":"Brandenburg","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B4","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1681\/ASN.2015091065","article-title":"A nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.surg.2003.07.001","article-title":"Therapy for calciphylaxis: an outcome analysis","volume":"134","author":"Arch-Ferrer","year":"2003","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K\u2013\u2013dependent carboxylation of matrix gla protein influences the risk of calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DAD.0000000000000824","article-title":"Histopathology of calciphylaxis: cohort study with clinical correlations","volume":"39","author":"Chen","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ijd.13622","article-title":"Early clinical presentations and progression of calciphylaxis","volume":"56","author":"Ghosh","year":"2017","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.mayocp.2016.06.026","article-title":"Calciphylaxis: a disease of pannicular thrombosis","volume":"91","author":"el-Azhary","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.kint.2018.03.016","article-title":"Questionable specificity of histologic findings in calcific uremic arteriolopathy","volume":"94","author":"Ellis","year":"2018","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.kint.2018.04.019","article-title":"Cutaneous calcification in patients with kidney disease is not always calciphylaxis","volume":"94","author":"Nigwekar","year":"2018","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gfw025","article-title":"Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?","volume":"31","author":"Brandenburg","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.10221014","article-title":"The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial","volume":"10","author":"Floege","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.03520414","article-title":"Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis","volume":"10","author":"Ishani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate","volume":"43","author":"Cicone","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2014.05.005","article-title":"Adipocyte induced arterial calcification is prevented with sodium thiosulfate","volume":"449","author":"Chen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/nep.13081","article-title":"Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients","volume":"23","author":"Peng","year":"2018","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2018.06.001","article-title":"Calciphylaxis in patients with normal renal function: a case series and systematic review","volume":"93","author":"Bajaj","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B19","first-page":"231","article-title":"Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates","volume":"83","author":"Torregrosa","year":"2015","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/2013.jamadermatol.5","article-title":"Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis","volume":"149","author":"el-Azhary","year":"2013","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/ijd.13685","article-title":"Direct oral anticoagulant medications in calciphylaxis","volume":"56","author":"King","year":"2017","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamadermatol.2018.1535","article-title":"Strengthening the case for the role of thrombophilia in calciphylaxis","volume":"154","author":"Hickson","year":"2018","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000491881","article-title":"The successful use of apixaban in dialysis patients with calciphylaxis who require anticoagulation: a retrospective analysis","volume":"48","author":"Garza-Mayers","year":"2018","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/nep.12433","article-title":"Hyperbaric oxygen in the treatment of calciphylaxis: a case series and literature review","volume":"20","author":"An","year":"2015","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2215\/CJN.09910917","article-title":"Opioid analgesics and adverse outcomes among hemodialysis patients","volume":"13","author":"Ishida","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B26","first-page":"310","article-title":"Calciphylaxis treated with neurolytic lumbar sympathetic block: case report and review of the literature","volume":"3","author":"Green","year":"2000","journal-title":"Reg Anesth Pain Med"},{"key":"key\n\t\t\t\t2019010207490231500_hcy234-B27","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/bjd.15702","article-title":"Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review","volume":"177","author":"Riemer","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/1\/29\/27363972\/hcy234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:07:09Z","timestamp":1775243229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/112\/1\/29\/5126239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcy234","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,10,10]]}}}